NASDAQ:PRTC PureTech Health (PRTC) Stock Price, News & Analysis → A lot of people are making this costly mistake (From WealthPress) (Ad) Free PRTC Stock Alerts $28.65 -0.01 (-0.03%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$28.36▼$28.8450-Day Range$22.05▼$30.9152-Week Range$17.08▼$33.07Volume5,054 shsAverage Volume4,311 shsMarket Capitalization$773.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get PureTech Health alerts: Email Address PureTech Health MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.02% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.12Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($4.67) to ($3.65) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.54 out of 5 starsMedical Sector881st out of 938 stocksPharmaceutical Preparations Industry404th out of 433 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for PureTech Health. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.02% of the outstanding shares of PureTech Health have been sold short.Short Interest Ratio / Days to CoverPureTech Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PureTech Health has recently decreased by 2.33%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldPureTech Health does not currently pay a dividend.Dividend GrowthPureTech Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRTC. Previous Next 3.4 News and Social Media Coverage News SentimentPureTech Health has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for PureTech Health this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added PureTech Health to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PureTech Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.30% of the stock of PureTech Health is held by insiders.Percentage Held by InstitutionsOnly 0.04% of the stock of PureTech Health is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for PureTech Health are expected to grow in the coming year, from ($4.67) to ($3.65) per share.Price to Book Value per Share RatioPureTech Health has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About PureTech Health Stock (NASDAQ:PRTC)PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies. It is also developing LYT-300, an oral allopregnanolone, currently completed Phase 1 stage, to treat depression, anxiety, and related indications; and LYT-310, an oral cannabidiol, currently under preclinical stage, to treat epilepsies and other neurological indications. In addition, the company is developing LYT-503/IMB-150, a non-opioid inflammation targeted disease immunomodulation for the potential treatment of interstitial cystitis, or bladder pain syndrome; and Glyph technology platform, a lymphatic-targeting chemistry platform, which leverages the body's natural lipid absorption and transports the process to orally administer drugs via the lymphatic system. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $27.54March 21, 2024 | americanbankingnews.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $25.85March 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 18, 2024 | businesswire.comBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionMarch 13, 2024 | finance.yahoo.comPureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 3.000 callFebruary 27, 2024 | lse.co.ukPureTech notes positive results from Shionogi's EndeavorRx ADHD trialFebruary 27, 2024 | finance.yahoo.comPureTech to Present at Two Upcoming Investor ConferencesMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…February 27, 2024 | businesswire.comPureTech to Present at Two Upcoming Investor ConferencesFebruary 27, 2024 | finance.yahoo.comPureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 27, 2024 | businesswire.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 22, 2024 | finance.yahoo.comPureTech Health plc (PRTC)February 15, 2024 | finance.yahoo.comDown -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a TurnaroundFebruary 9, 2024 | fool.co.ukLSE:PRTC (PureTech Health plc)January 23, 2024 | seekingalpha.comPRTC PureTech Health plcDecember 20, 2023 | msn.comPureTech outlook for 2024December 7, 2023 | finance.yahoo.comPureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023November 14, 2023 | msn.comPureTech Phase 2 study for anti-anxiety drug LYT-300 meets primary endpointOctober 11, 2023 | finance.yahoo.comPureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual MeetingOctober 6, 2023 | bizjournals.comAt Women Who Lead in Life Sciences, female leaders got the spotlight [PHOTOS]October 5, 2023 | bizjournals.comThe Petri Dish: Flagship startup hires GSK leader; Biogen cuts digital health groupOctober 4, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track DesignationSeptember 28, 2023 | finance.yahoo.comKarXT, invented at PureTech, submitted for FDA Approval in SchizophreniaSeptember 27, 2023 | finance.yahoo.comPureTech Announces the Appointment of Robert Lyne as Chief Portfolio OfficerAugust 29, 2023 | msn.comHere’s why this could be one of the best UK growth stocks to buy right nowMay 11, 2023 | technews.tmcnet.comPURETECH DELIVERS NUMEROUS INNOVATIONS TO INCREASE ROI OF ITS LEADING WIDE AREA VIDEO SURVEILLANCE SOLUTION INCLUDING FALSE ALARM ELIMINATIONSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:PRTC CUSIPN/A CIK1782999 Webwww.puretechhealth.com Phone617-482-2333Fax617-482-3337Employees111Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio7.31 Quick RatioN/A Sales & Book Value Annual Sales$15.62 million Price / Sales49.26 Cash FlowN/A Price / Cash FlowN/A Book Value$19.64 per share Price / Book1.45Miscellaneous Outstanding Shares27,000,000Free Float25,564,000Market Cap$769.50 million OptionableNot Optionable Beta1.20 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 53)Founder, CEO & Executive Director Comp: $1.01MDr. Bharatt M. Chowrira J.D. (Age 59)Ph.D., President & Executive Director Comp: $800.55kDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Non-Executive Director Comp: $145kDr. David R. Elmaleh Ph.D. (Age 76)Co-Founder & Senior Advisor Ms. Allison Mead TalbotHead of Communications & Investor RelationsMr. Spencer BallSenior Vice President of Human ResourcesDr. Eric Elenko Ph.D. (Age 51)Chief Innovation & Strategy Officer Ms. Aleksandra Filipovic M.D.Ph.D., Head of OncologyMs. Cheryl Murphy Ph.D.Head of Grants Management & StrategyMs. Anita Terpstra J.D.Ph.D., Senior VP & Head of Intellectual PropertyMore ExecutivesKey CompetitorsTango TherapeuticsNASDAQ:TNGXEvolusNASDAQ:EOLSPraxis Precision MedicinesNASDAQ:PRAXAstria TherapeuticsNASDAQ:ATXSTyra BiosciencesNASDAQ:TYRAView All Competitors PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed in 2024? PureTech Health's stock was trading at $28.18 at the start of the year. Since then, PRTC shares have increased by 1.1% and is now trading at $28.50. View the best growth stocks for 2024 here. When is PureTech Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024. View our PRTC earnings forecast. How do I buy shares of PureTech Health? Shares of PRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRTC) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.